Відео

It is now time to boom! 28.dec.2024 watch out CKPT!

Someone get a hold of this creator... time to do an update on $SAVA YOU would get 1000's of views. Lots more has happened in last 3 years. Ph2 now 24+ months. Shows the data point he mentioned would like to see.

Good time to get back into sava if you aren’t in.. adding weekly🎉

what do you think of espr now. Looks a potential 10x maybe 20x win lawsuit and expand label.

Sava is a great buy now way more data P3 fully enrolled

Are you able to cover sava again ?

OLD !! get an interview now . That would getnerate a lot of interest

Sangamo update.please. wow.. it was dropped by biogen

Can we get an update here pretty please.

Pleaww give an update on Kodiak

dude….that was amazing analyst of KOD, so very insightful!! So summer of 23 brings major catalyst. KOD still on your watchlist? Top notch….thanks again!!

Hey man, you still watching this thing after all the drama?

@Breaking Biotech any thoughts on most recent data?

Does Julian Baker still own KOD ? It may have bottomed around $4.25 and I anticipate a rally into the July '23 Phase 3 Announcement which is pending.

HEPA Hepion Pharmaceuticals, Inc. $0.70 0.02 (+2.93%)

Seladelpar activates the delta form of PPAR, while elafibranor targets PPAR-alpha and PPAR-delta. Inventiva’s prospect hits all three: PPAR-alpha, PPAR-gamma and PPAR-delta.

Sio Gene Therapies is undergoing liquidation, with its shareholders likely to receive $0.38-$0.42/share vs. the current price of $0.40/share.

My portfolio is very biotechnology based ARDX - Entry at $0.595, now with 750%, the largest position in the portfolio where it reached a weight of more than 30%, but already trimmed/pruned/reduced CABA - Entrance at €1.02, retails at $8.49 with 488% PRVB - Buy at $7.63 sold at $24.32 at 210% (this was offered for acquisition by Sanofi at $25.00 a share, didn't wait to have money to invest sooner) INZY - Buy at $2.90, now at 110% VKTX - Buy at $10.30 now with 105% TGTX - Buy at $9.48, now at 133% PTGX- Buy at 12.10, now at 98% MDXH - Buy at $3.31, now at 19% XFOR - Buy at $1.06 now with 36% GRTX - Buy at $1.83 now with 51% Etc.

Novo Nordisk is hoping to keep its name off that list, but a midstage trial failure raises new concerns for its prospect. In a phase 2 trial of its highly successful Type 2 diabetes drug Ozempic (semaglutide) against NASH, the treatment was outdone by placebo by a wide margin.

Hey Matt. Do you intend to go further with this channel and do more videos? I was hoping to have your take on Cassava trials, since the last one you made was many months ago. I liked the last (deep and critical) analysis you did on Simufilan.

Good content. Hope for new updates soon

I miss your vids man

Vk-5211 does show functional improvement . Big time. I don’t believe half the things they say in these study’s to be honest.

Whatsever happened to this dude? I enjoyed his posts

Hi Matt, Now that TGTX has a FDA approval for Briumvi , are you back in the company. if yes what is your prediction of the share price- Thanks in advance

Hey Matt, I hope you're doing good! haven't had any updates for a while now. Wish you the best for 2023 and for your return :).

This guy is a fraud. He just steals people's money.

Dude we need an update video on Anavex

ONCT is chart is in the early stages of major reversal. Just broke the 50 day moving average.

Would love to know your latest thoughts after the positive topline RVO results!

I dig your shows, Matt. Cheers. Intriguing dvlptmt, rather devolution in KPTI. I remember missing out on the FDA approval rally way back in 2019, watching it take off to 25$/sh stratosphere, only to come down like Ikarus to 4's. Can U explain WHY the falling from grace, please ? PS check out BLUE.

Thank you for a good & informative video 👍

can you do a video on Relmad Tx? PH3 data expected in july. thx

I love supporting this company so much. They are combatting our societal norms. They're fighting non alcoholic fatty liver effects but also way more. Vk0612 is also tackling type 2 diabetes. Can't wait till those results come out. My brother had type 1 diabetes. That's how I found this company. Let's go. Thank you

This channel has such fantastic content there should be hundreds of thousands of subs

Please get Timothy Springer on the show

Great channel buddy

Can you do a recap on SELB if you find time

SELB is picking up steam

Great content a very undervalued channel. You have a great handle on this field

Can we get an Update on Selecta Bio please?

𝓹𝓻𝓸𝓶𝓸𝓼𝓶

This is a great highly informative channel, your a knowledgeable treasure trove of UA-camr

sucks to hear about the drop in frequency in episodes, but i get it. biotech has not been fun to follow or trade in the midst of a 1.5 year drawdown, and it makes sense that interest in bio is dwindling as a result. It's gotten to where people are even questioning its viability as a profitable economic model. Not sure what the future holds for your channel, but I hope better days come to the sector and interest increases in turn. And that all goes well for you. Thanks for all the content you've made thus far

Thank you to the episode sponsor - workinbiotech.com/

Hey Mathew, any thoughts on what’s happening with SELB? I have been averaging down but it seems to keep going down! I did my own dd and I think all the fundamentals are still there for the company! I would appreciate your input/thoughts!

thank Matt. good stuff. you almost make me feel better about the curis bag I'm holding

Appreciate the analysis. I’m planning to increase my CRIS position too. Current price level is crazy.